At Drexel Medicine’s Advanced Pathology Imaging Lab, Director Mark Zarella strives to deliver the same high-quality service patients might find at larger institutions. To reach that standard, Zarella committed to digital pathology almost 20 years ago, on the promise it would streamline clinical reporting workflows. Faster reporting would, in turn, give clinicians more time to … Read More
HistoTox Labs (HTL) provides pathology services to researchers, and requires flexibility and agility to handle large amounts of study data. Founded in 2003 and based in Boulder, Colorado, the lab is a full service, GLP-compliant contract research organization serving pharmaceutical, biotech, government, and academic clients. HTL specializes in preclinical immunohistochemistry and image analysis. Roger Pearce, … Read More
Meet Pathcore at meetings and conferences. View our event list in 2018.
Motic Instruments Inc., North America and Pathcore™ Inc. announce a new integration that significantly enhances user experience while expanding access to digital pathology imaging. This new venture provides superior organization and increased efficiency for Pathology teams and allows for easy collaboration across multiple locations.
Pathcore Partners with Visiopharm to Provide a Powerful Image Analysis and Management Solution for Digital PathologyHørsholm – Denmark, November 11, 2016 – Pathcore and Visiopharm today announced a partnership to provide enhanced workflow software solutions for quantitative analysis and management of digital pathology images. By leveraging the strengths of Visiopharm, a global industry leader of … Read More
TORONTO, Ontario – Today, digital pathology company Pathcore announced the launch of Pathcore Web, an advanced web-based image management platform for research teams working with whole slide pathology images. Pathcore Web is a secure, browser-based platform for managing pathology and radiology images. Research teams can create, analyze and share cases anywhere, at any time. It comes with a … Read More
Pathcore Joins MarS Impact8 Program$2.92M USD Investment by NCI Will Lead to Validated Clinical Cancer Diagnostic Algorithms Using Pathcore’s Technologies TORONTO, Ontario – January 22, 2016 12:17 PM EST – Pathcore™ and a team of investigators from the US and Canada have received an award from National Cancer Institute (NCI), a division of the National Institutes of Health … Read More